6月8日，Oscar Health盘中上涨5.79%，报26.175美元/股，成交额5963.03万美元。
消息面上，富国银行近日将公司评级从"跑输大盘"上调至"等权重"，目标价从11美元大幅提高至20美元，释放积极信号。分析师Stephen Baxter指出，上调主要基于对《平价医疗法案》市场信心增强，参保人数和医疗成本结果均好于预期。公司一季度总收入达46.5亿美元，同比增长53%；净利润6.79亿美元，合每股收益2.07美元，远超市场预期的1.10美元；会员人数达320万，同比增长56%。此前CTO兼联合创始人Mario Schlosser转为顾问角色曾引发市场对技术战略连续性的担忧，但评级上调叠加亮眼业绩有效对冲负面情绪，股价自低位持续走强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.